4-HO-MiPT

4-HO-MiPT
Clinical data
Other names	4-OH-MiPT; 4-Hydroxy-N-methyl-N-isopropyltryptamine; Miprocin
Routes of; administration	Oral
Drug class	Non-selective serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); DE: NpSG (Industrial and scientific use only); UK: Class A; US: Unscheduled;
Pharmacokinetic data
Onset of action	10–20 minutes
Duration of action	4–6 hours
Identifiers
	IUPAC name 3-{2-[methyl(propan-2-yl)amino]ethyl}-1H-indol-4-ol;
CAS Number	77872-43-6 ;
PubChem CID	10082683;
ChemSpider	8258221 ;
UNII	4GAJ9OJ8YZ;
ChEMBL	ChEMBL171419 ;
CompTox Dashboard (EPA)	DTXSID30228492 ;
Chemical and physical data
Formula	C14H20N2O
Molar mass	232.327 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	123 to 125 °C (253 to 257 °F)
	SMILES CN(C(C)C)CCC2=CNC1=CC=CC(O)=C12;
	InChI InChI=1S/C14H20N2O/c1-10(2)16(3)8-7-11-9-15-12-5-4-6-13(17)14(11)12/h4-6,9-10,15,17H,7-8H2,1-3H3 ; Key:RXKGHZCQFXXWFQ-UHFFFAOYSA-N ;
	(verify)

4-HO-MiPT, also known as 4-hydroxy-N-methyl-N-isopropyltryptamine or as miprocin, is a psychedelic drug of the tryptamine and 4-hydroxytryptamine families related to psilocin (4-HO-DMT). It appears to be similar to psilocin in terms of onset, duration, and effects. The drug is taken orally.

It acts as a non-selective serotonin receptor agonist, including of the serotonin 5-HT_2A receptor among others. The drug is closely related structurally to MiPT, 4-HO-DiPT, and psilocin (4-HO-DMT).

4-HO-MiPT was first described in the literature by David Repke and colleagues in 1981. Its effects in humans were subsequently described by Repke and Alexander Shulgin in 1985 and 1997.